Atlanta-based GeoVax Labs, Inc. has announced the start of two new human trials for an AIDS vaccine, beginning a month earlier than expected. The tests conclude a four-trial series that began in April 2006 and are being conduced at the HIV Vaccine Trials Network (HVTN) in Seattle, Washington.